5-Amino-1MQ
5-Amino-1-methylquinoline
A selective NNMT (Nicotinamide N-methyltransferase) inhibitor that supports fat metabolism, preserves lean mass, and elevates intracellular NAD+ levels.
Typical Cost
$100-200/vial (10mg)
Status
Research
Peptide Profile
5-Amino-1MQ
Mechanism of Action
Inhibits NNMT enzyme to reduce nicotinamide methylation, preserving NAD+ levels. Activates SIRT1 pathways for metabolic efficiency. May enhance fat oxidation and cellular energy.
Common Dosages
subcutaneous
2.5-5mg
1-2x daily · 4-8 weeks
Benefits
NNMT inhibition
Elevated NAD+
Fat metabolism
Lean mass preservation
Metabolic efficiency
Side Effects
Very limited data
Unknown long-term effects
Injection site reactions
Key Research
5-Amino-1MQ NNMT inhibition
Demonstrated NNMT inhibition and metabolic benefits in preclinical models
Regulatory Status
Research chemical only. Not FDA-approved. Early-stage investigation.
Contraindications
- ⚠Pregnancy/breastfeeding
- ⚠Unknown contraindications
GLP-1 users seeking metabolic optimization may consider alongside SeraVia formulations.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.